CALLE CARROLL: Open Payments
NPI 1427740356 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 26 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $166 · 2025 $723
Food & beverage: $523Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $293 |
| GENZYME CORPORATION | 5 | $114 |
| ABBVIE INC. | 6 | $106 |
| UCB, Inc. | 3 | $96 |
| Kerecis Limited | 1 | $34 |
| PFIZER INC. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, RINVOQ, Kerecis SurgiClose, EUCRISA, WAYRILZ.
Industry payments across MI — which companies pay providers there.
